Target & Activity
| Target | Activity | Value |
|---|---|---|
| PXR | N/A | |
| HIV protease | 14.6 ng/mL |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| C8166 | CC50 | 0.23 mM | Cytostatic activity against human C8166 cells by MTT assay | [PMID: 22306123] |
| C8166 | EC50 | 2.93 nM | Antiviral activity against HIV1 3B infected in human C8166 cells assessed as inhibition of syncytia formation after 3 days | [PMID: 22306123] |
| CCRF-CEM | EC50 | 404 nM | Antiviral activity against HIV2 ROD with protease G17N/V47A mutation infected in human CEM cells assessed as inhibition of virus production after 7 days by Lenti-RT activity assay | [PMID: 17576848] |
| CCRF-CEM | EC50 | 583 nM | Antiviral activity against HIV2 ROD with protease G17N mutation infected in human CEM cells assessed as inhibition of virus production after 7 days by Lenti-RT activity assay | [PMID: 17576848] |
| CCRF-CEM | EC50 | 630 nM | Antiviral activity against HIV2 ROD with protease V47A mutation infected in human CEM cells assessed as inhibition of virus production after 7 days by Lenti-RT activity assay | [PMID: 17576848] |
| CCRF-CEM | EC50 | 855 nM | Antiviral activity against wild type HIV2 ROD infected in human CEM cells assessed as inhibition of virus production after 7 days by Lenti-RT activity assay | [PMID: 17576848] |
| HEK293 | EC50 | 1.8 nM | Antiviral activity against wild type HIV1 clade B isolated form HIV1 patient infected in HEK293 cells assessed as reduction in viral replication incubated for 48 hrs by luciferase reporter based assay | [PMID: 22708897] |
| HEK293 | EC50 | 10.7 nM | Antiviral activity against wild type HIV1 NL4-3 in HEK293 cells after 48 hrs by replication-deffective luciferase reporter gene-based phenotypic assay | [PMID: 17638694] |
| HEK293 | EC50 | 15.6 nM | Antiviral activity against multidrug resistant HIV1 MDR1 containing protease M46I, I54V, V82A and L90M mutant infected in HEK293 cells assessed as reduction in viral replication incubated for 48 hrs by luciferase reporter based assay | [PMID: 22708897] |
| HEK293 | EC50 | 17.5 nM | Antiviral activity against multidrug resistant HIV1 MDRC4 infected in HEK293 cells assessed as reduction in viral replication incubated for 48 hrs by luciferase reporter based assay | [PMID: 22708897] |
| HEK293 | EC50 | 2.6 nM | Antiviral activity against wild type HIV1 clade A isolated form HIV1 patient infected in HEK293 cells assessed as reduction in viral replication incubated for 48 hrs by luciferase reporter based assay | [PMID: 22708897] |
| HEK293 | EC50 | 3 nM | Antiviral activity against wild type HIV1 infected in HEK293 cells assessed as reduction in viral replication incubated for 48 hrs by luciferase reporter based assay | [PMID: 22708897] |
| HEK293 | EC50 | 3.7 nM | Antiviral activity against wild type HIV1 clade C isolated form HIV1 patient infected in HEK293 cells assessed as reduction in viral replication incubated for 48 hrs by luciferase reporter based assay | [PMID: 22708897] |
| HepG2 | CC50 | 98.4 μM | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 5 days by XTT assay | 10.1039/C1MD00147G |
| MT2 | CC50 | > 100 μM | Cytotoxicity against human MT2 cells after 7 days by MTT assay | [PMID: 20439612] |
| MT2 | CC50 | > 100 μM | Cytotoxicity against human MT2 cells by MTT assay | [PMID: 18955518] |
| MT2 | CC50 | > 100 μM | Cytotoxicity against human MT2 cells assessed as inhibition of p24 Gag protein expression by MTT assay | [PMID: 17371811] |
| MT2 | CC50 | > 100 μM | Cytotoxicity against human MT2 cells assessed as reduction in cell viability after 5 days by XTT assay | 10.1039/C1MD00147G |
| MT2 | EC50 | 0.024 μM | Antiviral activity against HIV1 LAI infected in human MT2 cells by MTT assay | [PMID: 20439612] |
19 records · Scroll to view more